Keyphrases
Dimethyl Fumarate
100%
Multiple Sclerosis
100%
Reasons for Discontinuation
57%
Lymphopenia
28%
Adverse Events
28%
Discontinuation Rate
28%
Population-based Study
28%
Management Strategy
14%
Nationwide Registry
14%
Non-adherence
14%
Nationwide Population
14%
Disease Activity
14%
Active Disease
14%
Health Care Costs
14%
Male Patients
14%
Log-rank Test
14%
Denmark
14%
Treatment Duration
14%
Registry Study
14%
Cox Proportional Hazards
14%
Kaplan-Meier
14%
Gastrointestinal Adverse Events
14%
Survival Analysis
14%
Medicine and Dentistry
Multiple Sclerosis
100%
Fumaric Acid Dimethyl Ester
100%
Adverse Event
42%
Lymphocytopenia
28%
Survival Analysis
14%
Treatment Duration
14%
Disease Activity
14%
Diseases
14%
Health Care Cost
14%
Log Rank Test
14%
Population Research
14%
Pharmacology, Toxicology and Pharmaceutical Science
Fumaric Acid Dimethyl Ester
100%
Multiple Sclerosis
100%
Adverse Event
42%
Lymphocytopenia
28%
Population Study
14%
Disease
14%
Disease Activity
14%